3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine
C52H70N16O3 — CID 157067836
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine
3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine (PubChem CID 157067836) has the molecular formula C52H70N16O3 and a molecular weight of 967.24 g/mol. Its IUPAC name is 3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine.
Molecular Properties
| Compound Name | 3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine |
|---|---|
| PubChem CID | 157067836 |
| Molecular Formula | C52H70N16O3 |
| Molecular Weight | 967.24 g/mol |
| Exact Mass | 966.58 |
| IUPAC Name | 3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]propanoic acid;3-[3,5-dimethyl-1-(3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)pyrazol-4-yl]-1-[4-(pyridin-2-ylmethyl)piperidin-1-yl]propan-1-one;methane;2-(piperidin-4-ylmethyl)pyridine |
| SMILES | C.C.Cc1nn(-c2ccc3nnc(C)n3n2)c(C)c1CCC(=O)N1CCC(Cc2ccccn2)CC1.Cc1nn(-c2ccc3nnc(C)n3n2)c(C)c1CCC(=O)O.c1ccc(CC2CCNCC2)nc1 |
| InChI | InChI=1S/C25H30N8O.C14H16N6O2.C11H16N2.2CH4/c1-17-22(18(2)32(29-17)24-9-8-23-28-27-19(3)33(23)30-24)7-10-25(34)31-14-11-20(12-15-31)16-21-6-4-5-13-26-21;1-8-11(4-7-14(21)22)9(2)19(17-8)13-6-5-12-16-15-10(3)20(12)18-13;1-2-6-13-11(3-1)9-10-4-7-12-8-5-10;;/h4-6,8-9,13,20H,7,10-12,14-16H2,1-3H3;5-6H,4,7H2,1-3H3,(H,21,22);1-3,6,10,12H,4-5,7-9H2;2*1H4 |
| InChIKey | ACBVKDFROSWLGE-UHFFFAOYSA-N |
| XLogP | 7.19 |
| TPSA | 217.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 71 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 967.24 |
| LogP ≤ 5 | 7.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157067836 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.